AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 800 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 800 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 800 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 800 | -27.3% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 1,100 | -78.4% | 0.00% | – |
| Q2 2019 | $2,000 | – | 5,100 | +2450.0% | 0.00% | – |
| Q4 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 200 | -66.7% | 0.00% | – |
| Q4 2017 | $0 | – | 600 | +200.0% | 0.00% | – |
| Q3 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 200 | -97.3% | 0.00% | – |
| Q1 2017 | $6,000 | -66.7% | 7,513 | -56.6% | 0.00% | – |
| Q4 2016 | $18,000 | +5.9% | 17,313 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | -45.2% | 17,313 | -35.2% | 0.00% | -100.0% |
| Q2 2016 | $31,000 | +55.0% | 26,713 | +175.0% | 0.00% | +100.0% |
| Q1 2016 | $20,000 | -61.5% | 9,713 | -73.6% | 0.00% | -66.7% |
| Q4 2015 | $52,000 | – | 36,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
| Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
| Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
| SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
| Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
| Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
| Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
| COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
| BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |